It's that time of year! The Campaign for Modern Medicines has arrived in San Francisco for the 2016 BIO International Convention. This year we're joining more than 15,000 health care experts, industry leaders and passionate advocates, all eager to discuss new trends and policies that could lead to today's discoveries and tomorrow's breakthroughs.
There's a lot happening at BIO, so here's a quick look at some of the events and forums we're focusing on during the convention:
Casting a Wider Net in Alzheimer's Research: The Diversity of Today's Approaches and Signs of Progress
Tuesday, June 7
More than 5 million Americans have Alzheimer's today. Experts expect 40% growth in the patient population within the decade. However, results from recent clinical and preclinical research have breathed new life into the fight against the disease. Each day brings more and more understanding of the fundamental biology of the brain and what conditions may lead to the onset of Alzheimer's. Hear researchers, biotech CEOs, and patient advocates give firsthand accounts at how past shortcomings are turning into today's advances and tomorrow's solutions to improving brain health.
Fireside Chat with Robert Califf, MD, Commissioner, US Food and Drug Administration
Tuesday, June 7
This forum will include a one-on-one chat with Robert Califf, the current Commissioner of the United States Food and Drug Administration (FDA), who will discuss the future of the agency and its work in ensuring new treatments' safety and efficacy. Moderated by Steve Usdin, Senior Editor of BioCentury.
Common Ground: Finding New Ways to Pay for Needed Medicines
Wednesday, June 8
Eli Lilly and Company and Anthem, Inc., will share the story of their unique partnership built around the idea of value-based drug pricing. By viewing the industry through two different lenses, they've found common ground in the belief that innovative medicines are the most impactful and cost-effective way to help patients. The panel will be led by David Ricks, Lilly's Senior Vice President and President of Lilly BioMedicines and Dr. Samuel Nussbaum, Anthem's recently retired Executive Vice President and Chief Medical Officer.
Patient-Centered Initiatives : Opportunities for Global Rare Disease Policy Development
Wednesday, June 8
This session will cover the progress in rare disease policy by delving into legislation put in place to support rare disease patients in newer markets. Panelists will discuss the expansion of initiatives, such as Rare Disease National Plans, enacted in an effort to improve diagnosis, education, treatment and care. Leading voices in the global rare disease community will highlight recent developments in these countries and go over opportunities for further headway.
Patient Advocacy Pavilion
June 6 - 10
Eli Lilly and Company will run a special pavilion dedicated to patient advocacy both onsite and online! Throughout the week, the pavilion will play host to attendees representing various organizations and patient advocacy groups who will get the chance to share their passions and discuss why they've made the trip to BIO 2016.
Not able to attend in person this year, but want to stay in the loop about all the fascinating things BIO 2016 has in store? We've got you covered. For up-to-the-minute updates and live coverage of the convention, including the events listed above and many more, follow us on Twitter and Facebook - Happy BIO!